Vardenafil 10 mg is a familiar strength of conventional film-coated tablets used for erectile dysfunction. The 10 mg label is also encountered in the separate ODT product category, which creates an important identification issue: conventional 10 mg tablets and orally disintegrating 10 mg vardenafil are not automatically interchangeable.
U.S. film-coated product labeling includes a clinician-directed as-needed ED dosing framework, with considerations for timing, health conditions and drug interactions. A 10 mg strength printed on a box is not authorization to select a regimen without a prescription or to combine medicines when a response is not immediate.
This page explains the conventional tablet’s product identity and why equal numerical strength does not establish equivalence with Staxyn-style ODT. For detailed formulation differences, use the ODT guide; for regimen decisions, use the dosage guide.
A conventional 10 mg vardenafil hydrochloride tablet is a film-coated oral prescription product. It belongs to the FDA-labeled tablet family that also includes other strengths, and it is taken according to the exact product’s instructions in the context of erectile dysfunction treatment.
The labeler, tablet color and imprint can differ among approved generic manufacturers. Ask the pharmacy to identify the filled product rather than comparing it to an image of Levitra or an unrelated dissolving tablet.
Levitra was the branded film-coated product associated with the original U.S. vardenafil ED labeling. Original U.S. Levitra marketing ended, but separately approved generic film-coated products can remain relevant to current prescriptions.
A historical Levitra 10 mg listing is not an online stock guarantee. The Levitra lifecycle page explains the brand distinction, and the generic guide addresses approval and product identity.
Two products may display 10 mg but have different instructions and systemic exposure. The table prevents a common mistake: treating equal-strength labels as authorization to substitute.
Only the prescriber and pharmacist can determine which product is appropriate for a particular prescription.
| Feature | 10 mg film-coated tablet | 10 mg ODT |
|---|---|---|
| Dosage form | Conventional swallowed oral tablet | Dissolving tablet placed on tongue |
| Brand history | Levitra film-coated brand discontinued | Staxyn ODT brand discontinued |
| Systemic exposure | Film-coated reference profile | Higher exposure described for ODT |
| Interchangeability | Not an automatic substitute for ODT | Not an automatic substitute for film-coated |
| Prescription check | Conventional tablet must be specified or permitted | ODT product must be correctly prescribed |
| Inventory | Generic film-coated stock separately checked | Generic ODT stock separately checked |
U.S. labeling for conventional film-coated vardenafil generally describes as-needed use approximately 60 minutes before sexual activity; sexual stimulation remains necessary. Sixty minutes is a planning instruction, not a guaranteed time to an erection. The pharmacy label and clinician's directions control the individual prescription.
Meal composition, health factors and interacting medicines may affect prescribing or perceived response. The onset guide explains why absorption measures and clinical response are different. Do not take an extra tablet if the response is not immediate.
As-needed prescribing has labeled frequency limitations. Taking another tablet because the first response is delayed, or switching to a second PDE5 inhibitor, can increase adverse-effect risk and should not be done without appropriate medical direction.
The prescribed instructions, not the nominal 10 mg product label alone, control how often medicine can be used. Consult the pharmacist if the directions on a refill differ from those previously provided.
Ten milligrams is the usual labeled starting dose for many patients, not a safe default for every patient. With moderate hepatic impairment (Child-Pugh B), U.S. film-coated labeling limits the maximum to 10 mg and recommends a lower starting point; with ritonavir or cobicistat the listed ceiling can be as low as 2.5 mg in 72 hours. Other CYP3A4 inhibitors also carry product-specific restrictions.
Vardenafil is contraindicated with nitrates and riociguat and has QT-related precautions involving congenital long-QT syndrome and certain antiarrhythmics. The complete medication list must be reviewed by the prescriber; a patient should not improvise a smaller tablet or a different interval. Read the interaction hub.
A new generic fill may look different from a previous product because the approved applicant or labeler has changed. Appearance should be cross-checked with the imprint, container label and dispensing pharmacy records; photographs found online are not enough to establish authenticity.
If the medication looks unusual, is damaged or has labeling inconsistent with the prescription, contact the pharmacist before taking it. A legitimate substitution still needs an identifiable approved product and appropriate dispensing process.
The fact that 10 mg is a labeled strength does not mean that it is the right treatment for everyone or that it should be preferred to another ingredient. Selection depends on individual medical history, treatment experience, interaction risk and clinician judgment.
For a wider view of the available conventional tablet strengths, visit the strengths catalog. Its purpose is identification, not a ranking by potency.
Confirm that a valid prescription identifies conventional film-coated vardenafil, the 10 mg strength and the intended quantity. Ask which FDA-approved product will be dispensed, whether it is currently in stock and who can answer medicine questions.
For legitimate purchase and fulfillment steps, follow the buying guide rather than ordering from a seller that ignores prescriptions or represents an ODT as equivalent to the conventional tablet.
Yes. It is a U.S.-labeled strength of conventional film-coated vardenafil hydrochloride tablets.
No. ODT labeling describes different systemic exposure and specifically warns against automatic interchangeability.
No. Levitra contained vardenafil, but its original U.S. brand was discontinued; current generics are separately approved products.
No. Film-coated vardenafil is generally labeled for use approximately 60 minutes before activity, but sexual stimulation and individual factors affect response; timing is not guaranteed.
Do not independently repeat or change a prescription. Follow the clinician’s instructions and ask about any lack of response.
No. The combination is contraindicated because of the risk of dangerous low blood pressure.
No. Approved generic labelers may use different tablet appearances and imprints; verify the actual dispensed product.
Yes. Vardenafil is a U.S. prescription medication for erectile dysfunction.